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Summary
The epidemiological link between brucellosis in wildlife and brucellosis in livestock 
and people is widely recognised. When studying brucellosis in wildlife, three 
questions arise: (i) Is this the result of a spillover from livestock or a sustainable 
infection in one or more host species of wildlife? (ii) Does wildlife brucellosis 
represent a reservoir of Brucella strains for livestock? (iii) Is it of zoonotic 
concern? Despite their different host preferences, B. abortus and B. suis have 
been isolated from a variety of wildlife species, whereas B. melitensis is rarely 
reported in wildlife. The pathogenesis of Brucella spp. in wildlife reservoirs is not 
yet fully defi ned. The prevalence of brucellosis in some wildlife species is very low 
and thus the behaviour of individual animals, and interactions between wildlife 
and livestock, may be the most important drivers for transmission. Since signs of 
the disease are non-pathognomonic, defi nitive diagnosis depends on laboratory 
testing, including indirect tests that can be applied to blood or milk, as well as 
direct tests (classical bacteriology and methods based on the polymerase chain 
reaction [PCR]). However, serological tests cannot determine which Brucella 
species has induced anti-Brucella antibodies in the host. Only the isolation of 
Brucella spp. (or specifi c DNA detection by PCR) allows a defi nitive diagnosis, 
using classical or molecular techniques to identify and type specifi c strains.
There is as yet no brucellosis vaccine that demonstrates satisfactory safety and 
effi cacy in wildlife. Therefore, controlling brucellosis in wildlife should be based 
on good management practices. At present, transmission of Brucella spp. from 
wildlife to humans seems to be linked to the butchering of meat and dressing of 
infected wild or feral pig carcasses in the developed world, and infected African 
buffalo in the developing world. In the Arctic, the traditional consumption of raw 
bone marrow and the internal organs of freshly killed caribou or reindeer is an 
important risk factor.
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Introduction
Brucellosis is a major zoonotic bacterial disease, widely 
distributed in mammals, both humans and animals. The 
occurrence of the disease in humans depends largely on the 
occurrence of brucellosis in an animal reservoir, including 
wildlife. In 1887, Sir David Bruce isolated the organism 
(Micrococcus melitensis) responsible for the ‘Malta fever’ from 
a British soldier who died from the disease in Malta. This 
bacterium was renamed Brucella melitensis in his honour. In 
1905, Themistocles Zammit demonstrated, again in Malta, 
the zoonotic nature of B. melitensis by isolating it from goats’ 
milk. Today, the disease is mainly occupational in humans 
(abattoir, animal industry, hunters and health workers) but 
transmission through the consumption of raw milk and 
milk products remains important in developing countries. 
Symptoms such as undulant (rising and falling) fever, 
tiredness, night sweats, headaches and chills may drag on 
for as long as three months before the illness becomes so 
severe and debilitating as to require medical attention (29). 
Brucellosis in animals is clinically characterised by one or 
more of the following signs: abortion, retained placenta, 
orchitis and epididymitis, with excretion of the organisms 
in semen, uterine discharges and in milk.
The epidemiological link between wildlife and many 
diseases in livestock is now well recognised. The long-
standing confl ict between livestock owners and animal 
health authorities, on the one hand, and wildlife 
conservationists on the other, is largely based on differing 
attitudes to controlling livestock diseases which are, or can 
be, associated with wildlife. The creation of new interfaces 
between livestock and wildlife due to human activity is 
the most important factor in disease transmission (7). 
Translocation or the introduction of infected animals into 
a non-endemic area and a lack of disease surveillance in 
wildlife may increase these interfaces (8). Thus, when 
studying brucellosis in wildlife, three main questions arise: 
– Is wildlife brucellosis the result of a spillover from 
livestock or is it a sustainable infection in one or more host 
wildlife species? 
– Does wildlife brucellosis represent a reservoir of Brucella 
strains for livestock? 
– Is wildlife brucellosis of zoonotic concern?
To resolve potential confl icts between ecologists, regulatory 
veterinarians, the production animal industry, the hunting 
industry and public health authorities, the approach to 
wildlife brucellosis has evolved from the general diagnosis 
of brucellosis to include (early) detection of a pre- or 
subclinical infection and identifi cation of transmission 
routes between different host species at the livestock/
wildlife interface. This general approach is aimed at taking 
preventive control and management measures to decrease 
the number of interfaces between livestock, wildlife and 
humans, and reduce the risk of brucellosis in both livestock 
and free-ranging/captive wildlife, thus also minimising the 
potential for zoonotic transmission (44).
Causative agents
Brucellae are Gram-negative, facultative intracellular 
bacteria that can infect many mammalian species, including 
humans. Ten species are recognised within the genus 
Brucella:
–  a group composed of six ‘classical’ Brucella species, some 
of which include different biovars: B.  abortus (biovars 1, 2, 
3, 4, 5, 6, 7, 9), B. melitensis (biovars 1, 2, 3), B. suis (biovars 
1, 2, 3, 4, 5), B. ovis, B. canis and B. neotomae (3, 14) 
– a group represented by the ‘new’ recently described 
species: B. ceti and B. pinnipedialis (32), B. microti (88) and 
B. inopinata (89). The distinction between species and 
biovars is currently made by several differential laboratory 
tests (3, 14). 
Classifi cation of the classical species was based mainly on 
differences in microbiological and molecular characteristics, 
host preference(s) and pathogenicity. In 1985, it was 
proposed that the Brucella species should be grouped as 
biovars of a single nomen species, based on DNA-DNA 
hybridisation studies (94). However, this change has never 
been accepted by the international community of Brucella 
researchers, and a return to the pre-1986 taxonomy 
was advocated and eventually adopted by the Brucella 
Taxonomic Subcommittee (68).
Worldwide, the main pathogenic species for livestock are:
– B. abortus (all biovars), responsible for bovine brucellosis
– B. melitensis (all biovars), the main causative agent of 
brucellosis in both small ruminants and humans
– B. suis (biovars 1, 2 and 3), responsible for swine 
brucellosis
– B. ovis, which causes brucellosis in sheep.
If brucellosis occurs in a herd or fl ock, national and 
international veterinary regulations impose restrictions on 
animal movements and trade, which can result in huge 
economic losses (29, 97).
Despite their respective host preferences, B. abortus and 
B. suis have also been isolated from a great variety of wildlife 
species, such as bison (Bison bison), elk/red deer (Cervus 
elaphus), feral swine and wild boar (Sus scrofa), the red fox 
(Vulpes vulpes), the European brown hare (Lepus europaeus), 
African buffalo (Syncerus caffer), reindeer (Rangifer tarandus 
tarandus) and caribou (Rangifer tarandus groenlandicus). For 
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this reason, wildlife must be considered a potential reservoir 
for brucellosis in livestock (16, 40, 78). Brucella melitensis 
is rarely reported in wildlife. However, sporadic cases have 
been reported in Europe in chamois (Rupicapra rupicapra) 
and ibex (Capra ibex) in the Alps (28, 37).
Brucella ovis and B. canis (responsible for ovine epididymitis 
and canine brucellosis, respectively) have never been 
reported in wildlife in Europe. However, B. ovis infection 
has been reported in red deer in New Zealand (79). For 
B. neotomae, only strains isolated from desert rats in Utah in 
the United States (USA) have been reported (29). 
Since the fi rst description of an abortion due to Brucella spp. 
in a captive dolphin in California in 1994 (26), several 
reports have described the isolation and characterisation 
of Brucella spp. from a wide variety of marine mammals, 
such as seals, porpoises, dolphins and whales, in almost 
all the waters covering the globe. Although brucellosis 
seropositivity has been documented in Antarctic seals, 
there has been no isolation of Brucella spp. from this animal 
so far (for a review, see 65). The overall characteristics of 
marine mammal strains are different from those of any of 
the six ‘classical’ Brucella species and, since 2007, B. ceti 
and B. pinnipedialis (preferentially infecting cetaceans and 
pinnipeds, respectively) have been recognised as new 
Brucella species (32). 
During the years 1999 to 2003, an acute disease was reported 
in the common vole (Microtus arvalis) in South Moravia 
(Czech Republic). A new Brucella species (B. microti) was 
isolated and characterised from clinical samples of diseased 
voles (51, 88). Brucella inopinata was recently isolated from 
a breast implant infection in an elderly woman with clinical 
signs of brucellosis (89). At this time, B. inopinata has not 
been isolated from any animal reservoir.
Experimental studies and epidemiological evidence suggest 
that birds are very resistant to Brucella spp. infection. On the 
other hand, it has been shown that B. melitensis biovar 3 can 
be cultured from both skin swabs and the visceral organs of 
Nile catfi sh (23, 83). These fi ndings suggest that fi sh may 
also be susceptible to B. ceti and B. pinnipedialis infection, 
which would have veterinary public health implications, 
given the potential zoonotic concern of these Brucella 
species, and this warrants further investigation. Brucellosis 
in marine mammals will be addressed elsewhere and will 
not be discussed further in this review.
Epidemiology
Spillover versus sustainable infection
One very important issue related to brucellosis in terrestrial 
wildlife is how to distinguish between a spillover of infection 
from livestock and a sustainable infection in wildlife. If the 
latter does exist, the concern of the livestock industry is to 
prevent the re-introduction of the infection into livestock, 
particularly in regions or states that are ‘offi cially free from 
brucellosis’ because of the costs linked to pre-movement 
testing.
It should be emphasised that the introduction of infected 
individuals into a healthy population is not, on its own, 
suffi cient to cause the effective transmission of Brucella spp. 
within a given wildlife host. The probability of brucellosis 
becoming established and being sustainable in a wild species 
will be less than the probability of infection, and close to 
zero in some cases. This is because sustainability depends 
on a combination of factors, including: host susceptibility 
(or resistance), infectious dose, (repeated) contacts with 
infected animals, and management and environmental 
factors (36). In North America, the highest probability of 
transmission of infectious agents between wildlife and 
cattle occurs in the extensive management systems used 
to raise beef cattle. Wildlife and cattle ranges overlap, 
and feed, water and mineral sources are shared between 
species on many farms and ranches (93). The development 
of the game-farming industry has contributed to the re-
emergence of brucellosis as an international concern for both 
livestock and wildlife, by increasing the density of potentially 
infected game species and the introduction of artifi cial 
feeding (78, 93). Brucella spp. cannot multiply outside 
their mammalian hosts but may remain viable within 
the environment for a period of time (several years for 
B. microti). In general, the viability of Brucella spp. outside 
the mammalian host is enhanced by cool temperatures and 
moisture and limited by high temperatures, dryness and 
direct exposure to sunlight. For example, B. abortus survives 
a couple of hours under direct sunlight but up to 185 
days in the cold and shade. Brucella abortus also survives 
in aborted fetuses, manure and water for periods of up to 
150 to 240 days (81). The epidemiological importance of 
environmental contamination as a source of Brucella spp. 
for wildlife, scavengers and non-target species has to be 
assessed on a case-by-case basis, but the possibility of direct 
transmission from an infected host must be excluded fi rst. 
The following sections will review the epidemiology of 
different Brucella species in terrestrial wildlife.
Brucella abortus
Since brucellosis eradication efforts in the European Union 
(EU) and in the USA focused on bovine brucellosis, the 
emphasis in these countries was put on the identifi cation 
of a possible reservoir of B. abortus in wildlife. When 
brucellosis was prevalent in cattle, numerous surveys 
identifi ed occasional seropositive results in wild ungulates, 
particularly cervids (78, 93), and under free-ranging 
conditions, the infection was considered self-limiting or 
the consequence of spillover from infection in cattle. For 
example, in 1995, B. abortus was isolated from 7/112 culled 
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chamois but brucellosis did not seem to be present in larger 
areas of the Western Italian Alps, where bovine brucellosis 
is absent (27).
Nowadays, in countries where bovine brucellosis 
eradication programmes are close to their end, there are no 
known sustainable reservoirs of B. abortus in wild species, 
other than bison and elk in and adjacent to the American 
National Parks of the Greater Yellowstone Area (GYA) and in 
the Canadian Wood Buffalo National Park. However, recent 
studies in feral pigs on the Atlantic coast of South Carolina, 
USA, may challenge these thoughts. Indeed, B. abortus 
wild-type and the B. abortus S19 and RB51 vaccine strains 
have been isolated from feral pigs on a property where no 
cattle had been kept since at least 1970 (90). Although these 
fi ndings need further confi rmation, this is the fi rst report of 
a wildlife reservoir of B. abortus outside the GYA in the USA. 
In Europe, the isolation of B. abortus in wild boar has, so far, 
not been reported. 
In Africa, the African buffalo is considered a reservoir 
of B. abortus (9). In Zimbabwe, antibodies against 
Brucella spp. have been detected mainly in buffalo, which 
were considered a possible source of infection for domestic 
stock (59). However, in a recent study in Zimbabwe, no 
anti-Brucella antibodies were detected in buffalo in an 
area where 9.9% of cattle tested positive (45). A recent 
report from Botswana suggests that household practices 
for processing buffalo bushmeat represent a signifi cant 
Brucella spp. exposure risk to family members and the 
community (2). In areas of livestock and wildlife interaction, 
brucellosis seropositivity has been reported in Kafue lechwe 
antelope (Kobus leche kafuensis) (60) and in unspecifi ed 
wildlife in Uganda (63). 
A recent survey in the Iberian Peninsula highlighted that 
wild ruminants were not a signifi cant brucellosis reservoir 
for livestock (61). Brucella abortus biovar 1 was only isolated 
from a single red deer, probably as a spillover from infected 
cattle. Thus, these results suggest that, in Europe, wild 
ruminants are occasional victims of brucellosis transmitted 
from infected livestock, rather than true reservoirs of the 
infection for livestock (61). The available epidemiological 
information suggests that wild ruminants are not able to 
sustain B. abortus infection without introductions from 
infected cattle. Given the progress in the eradication 
programme of bovine brucellosis in the EU Member States, 
it is unlikely that B. abortus will become a threat to wildlife 
in the EU in the future.
Brucella melitensis
The known ecological range of B. melitensis in wildlife is 
more restricted than those of B. abortus and B. suis, although 
it is still a major problem in small ruminants in southern 
European states. Spillover from infected small ruminants 
has been documented in a few wildlife species, such as 
chamois (R. rupicapra) and ibex (C. ibex) in the French and 
Italian Alps (28, 37), and the Iberian wild goat in Spain 
(61), suggesting that these wild species are unable to sustain 
the infection and thus cannot act as reservoirs for domestic 
animals and human beings. These reports highlight the fact 
that B. melitensis infection in European wildlife is nowadays 
anecdotic and always linked to the small ruminant 
reservoir. Given the effective eradication of small ruminant 
brucellosis in Northern and Central Europe a long time ago, 
and the important progress made by B. melitensis eradication 
programmes in some Mediterranean EU Member Countries, 
this infection will probably not become a relevant issue in 
the future. However, important foci of B. melitensis persist 
in small ruminants in the Balkans, possibly threatening the 
wild ruminants of this region.
In the Middle East, B. melitensis has been isolated from an 
Arabian oryx (Oryx leucoryx) in Saudi Arabia (69). However, 
most B. melitensis infection cases occur in nomadic one-
humped camels (Camelus dromedarius) that have been in 
contact with sheep and goats (1). The same situation occurs 
in the two-humped camel (C. bactrianus) and yak (Bos 
grunniens) in Central Asia (80). Brucella melitensis has been 
isolated from camel milk, indicating that camels may also 
constitute a serious public health problem (48). Brucellosis 
also occurs in llamas and other small camelids in some 
South American countries (29), but its epidemiological 
relevance is unknown. There is no documented report of 
the isolation of B. melitensis in wildlife in North America. 
In Africa, B. melitensis has been isolated once, from a 
sable antelope (Hippotragus niger) in 2005 (M. McFarlane, 
personal communication).
Brucella suis
Brucella suis (biovars 1, 2, 3) is still widely distributed 
in the world, although information is scarce in Africa 
(58), where no isolation of B. suis has been documented 
in the international scientifi c literature. Brucella suis 
biovar 3 has only been isolated in South-East Asia and 
America. Generally, the prevalence in domestic pigs is low, 
with the exceptions of those in South-East Asia and Central 
and South America. Brucella suis infection transmitted from 
the pig reservoir has been reported in cattle (13) and dogs 
(77), but the epidemiological importance of these fi ndings 
is unknown. A recent report described the isolation of 
atypical B. suis biovar 3 in horses in Croatia (15). Further 
molecular studies grouped these Croatian strains with B. suis 
biovar 1 isolates (33). The taxonomical relevance of B. suis 
biovar 3 or, at least, the representativeness of its reference 
strain is questionable, since there is no single fi eld strain 
of B. suis that matched both microbiological and molecular 
profi les of the biovar 3 reference strain (33).
Brucella suis infection due to biovar 1 is restricted to feral 
pigs in the USA and Australia, with human infections 
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linked to butchering swine being regularly reported (20, 
84). Brucella suis biovar 1 has been isolated from people, 
domestic pigs (57) and collared peccaries (Tayassu tajacu) 
in South America (56). In Croatia, during the period 1980–
2003, B. suis biovar 1 was isolated from wild boar, hares, 
domestic pigs and horses (35). However, to date, no human 
B. suis biovar 1 infection has been reported in Croatia (72). 
In 1993, B. suis biovar 1 was isolated in Belgium from a 
butcher handling imported feral pig meat. The most recent 
B. suis biovar 1 infection before that had been reported in a 
pig farmer in 1983 (43).
Brucella suis biovar 2 infection remains restricted to wild 
boar and European brown hares in Europe, where B. suis 
has been eradicated in the intensive domestic pig industry 
for decades. The available evidence suggests that wild boar 
seem to be the main source of infection for domestic pigs, 
since several outbreaks of B. suis biovar 2 have occurred in 
outdoor rearing systems, even on fenced premises, with the 
source of infection being traced back to contacts with wild 
boar. Transmission from wild boar to pigs is thought to be 
through the venereal route, as crossed (striped) piglets have 
been reported, at least in France and Portugal; however, 
other routes might also be possible (24). The role of wild 
boar hunting (migration pressure, offal remaining in the 
fi eld, hunters working on the premises, etc.) has not been 
fully investigated (24).
The geographical distribution of biovar 2 has historically 
occurred in a broad range between Scandinavia and the 
Balkans. In recent years, several reports of B. suis biovar 2 
infections in wild boar and the European hare have been 
published from the Iberian peninsula (61) to central Europe 
(73, 91).
The role of hares in the dissemination of brucellosis should 
be of lesser importance than that played by wild boar, due 
to the particular migratory behaviour of the latter. Solitary 
wild boar adult males may range very long distances if 
disturbed or in the case of food shortage, whereas hares have 
a non-migratory way of life and occupy small home ranges, 
reducing the interface with other wildlife. However, ten 
clinical outbreaks of B. suis biovar 2 infection were recorded 
in domestic pigs in Denmark between 1929 and 1999, and 
epidemiological evidence linked these outbreaks to hares. 
Brucella suis biovar 2 infections in cattle have also been 
reported in Denmark (4) and the source of contamination 
is believed to have been hares, since there is no established 
population of free-ranging wild boar in Denmark. Hares 
have been considered as a possible source of B. suis 
biovar 2 outbreaks in domestic pigs via swill feeding with 
offal from hunted infected hares. Some reported outbreaks 
have also been traced to the introduction of infected live 
animals, originating from holdings where the disease had 
not been detected (24). There is no information available 
on the presence of B. suis biovar 2 in the mountain hare 
(Lepus timidus) in Northern Europe (24). In contrast to 
B. suis biovars 1 and 3, which can cause severe disease in 
humans, B. suis biovar 2 has only been isolated in a very 
small number of patients (38). 
Brucellosis in reindeer and caribou (also named rangiferine 
brucellosis) is caused by B. suis biovar 4 throughout the 
Arctic region (Siberia, Canada and Alaska, with the exception 
of Norway) and constitutes a serious zoonotic problem 
(30). In Canada and Alaska, human cases were restricted 
to herders of diseased reindeer or caribou. All the patients 
were clinically ill native people who ate caribou as part of 
their diet. Part of a freshly killed caribou is often eaten raw, 
including bone marrow and some internal organs, known 
to contain high numbers of B. suis biovar 4 (30). Recently, 
the Alaska Native Tribal Health Consortium published 
bulletins on brucellosis in Alaska. (These bulletins can be 
downloaded at: www.anthctoday.org/community/climate_
health.html.) It has been experimentally demonstrated 
that cattle exposed to B. suis biovar 4-infected reindeer can 
become infected (31). Brucella suis biovar 4 may also infect 
moose and musk ox (Ovibos moschatus) and, occasionally, 
carnivores (30). A recent serological study concluded 
that brucellosis was not present in reindeer in Finnmark, 
northern Norway (5). Brucella suis biovar 5, isolated in 
rodents in Eastern Europe and of which very few strains 
are known, is most probably misidentifi ed and will not be 
discussed further.
Brucella microti
As mentioned previously, a systemic disease occurred in 
a wild population of the common vole in South Moravia 
(Czech Republic) during the years 1999–2003. From the 
clinical samples, small Gram-negative coccobacilli were 
isolated and identifi ed as Ochrobactrum intermedium (51). 
However, subsequent analysis identifi ed the strains as 
Brucella spp., representing a novel species within the genus 
Brucella, to which the name B. microti was given (88). 
Long-term survival of B. microti in soil was described and, 
thus, soil might act as a reservoir of infection (87). Brucella 
microti was also isolated from the mandibular lymph nodes 
of red foxes hunted in the region of Gmünd, Lower Austria. 
Brucella microti is thus prevalent in a larger geographical 
area, covering the region of South Moravia and parts of 
Lower Austria, and foxes could have become infected 
by ingesting infected common voles (86). No human or 
livestock infection with B. microti has been reported to date.
Pathogenesis
The sequence of events following the introduction of Brucella 
infection in wildlife is believed to be quite similar to that 
described during brucellosis infections in domestic animal 
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species. There is generally a relatively long latency period 
before clinical signs appear, mostly dependent on the 
age, sex and physiological condition of the animal. The 
Brucella entry sites are essentially the oral, nasopharyngeal, 
conjunctival and sexual mucosae. After penetration, 
a submucosal infl ammatory reaction, characterised 
by infi ltrates of mononuclear, polymorphonuclear 
and eosinophilic leucocytes, is produced. Invading 
bacteria are moved to regional lymph nodes through 
lymphatic drainage. Under experimental conditions, 
Brucella remains confi ned to the target lymph nodes 
close to its entry sites for two to three weeks. With the 
development of lymphadenitis, the bacteria reach the blood 
via the efferent lymph, and bacteraemia leads to a generalised 
infection of the reticulo-endothelial organs, lymph nodes 
distant from the entry sites, and genital and extragenital 
organs and accessory sexual glands. Brucellae can be 
isolated from the liver, kidney, spleen, testes, epididymis, 
vesicular glands, prostate, bulbo-urethral glands, uterus, 
mammary glands, bone marrow and most lymph nodes: 
submaxillary, parotid, retropharyngeal, prescapular, 
precrural, supramammary, iliac and genital lymph nodes. 
For this reason, excretion of the microorganism in milk, 
vaginal discharges in females and semen in males are the 
most important mechanisms for spreading the infection. 
Other organs, such as the brain, vertebral column and 
synovial structures, can also be found to be infected with 
Brucella in some animals (41, 81).
However, the prevalence of brucellosis in some 
wildlife species is very low and thus, besides the classical 
factors considered to be important in transmission (host 
susceptibility, shedding, survival in the environment, 
etc.), the behaviour of individuals and interactions 
between wildlife and livestock may actually be the most 
important drivers for transmission. For instance, the 
reclusive calving behaviour of elk, which keeps the elk cow 
and calf away from the herd for several days after calving, 
minimises the risks of B. abortus transmission to other 
animals and, in free-ranging settings, elk may be looked 
upon as a potentially dead-end host. On the other hand, in 
situations with important anthropic effects (i.e. intentional 
winter feeding of wild animals, or unintended co-mingling 
of wildlife on livestock feed grounds), the risk of infection 
increases dramatically, due to increasing density and 
enhanced risk of exposure to an infectious abortion near 
the feeding grounds, resulting in feed contamination. In 
the GYA, winter feeding changed the behaviour and density 
of free-ranging elk, probably converting what would 
otherwise be a dead-end host in nature to a maintenance 
host of B. abortus (93). As documented recently in the 
context of bovine tuberculosis due to Mycobacterium bovis, 
specifi c individuals with relatively high contact rates, in 
both cattle and badger populations, have the potential to act 
as hubs in the spread of disease through complex contact 
networks (9).
Clinical signs
Brucellosis in wildlife is characterised by reproductive 
disorders: abortion, retention of the placenta, metritis, 
subclinical mastitis, infertility, orchitis or epididymitis 
with frequent infertility or sterility, as well as articular and 
peri-articular hygromas, seen more frequently in chronic 
infections. Abortion is the main sign of clinical brucellosis, 
and often occurs during the second half of the gestation 
(41, 81). In 75% to 90% of cases, the animal will abort only 
once. Finally, a given number of animals born from Brucella-
infected females may be latent carriers (approximately 5%) 
and can only be identifi ed by immunological tests after 
their fi rst or second pregnancy (47, 74).
Gross and 
microscopic pathology
In general, Brucella spp. infection in wildlife causes a 
similar pathology to the lesions in domestic animals (18). 
Brucellae have a predilection for the gravid uterus, udder, 
testicle and accessory male sex glands, lymph nodes, joint 
capsules and bursae. Infected animals develop placentitis, 
which results in abortion or premature or weak offspring 
and increased perinatal mortality. Placental retention also 
occurs in a signifi cant proportion of animals. After abortion, 
the placenta may be oedematous and hyperaemic, and the 
fetus may have haemorrhagic fl uid in the peritoneal space 
and subcutaneous tissues. Metritis sometimes occurs, and 
nodules and abscesses may be found in both the gravid 
and non-gravid uterus. Lesions in the uterus are frequent 
sequelae, being the main reason for infertility. Although the 
number of infected males with testicular alterations is not 
usually high, an important proportion of infected males 
excrete Brucella in semen. After necropsy, infl ammatory 
lesions, abscesses or calcifi ed foci may be seen in the testes 
and accessory sexual glands and organs, particularly the 
epididymis and seminal vesicles. Testicular atrophy and 
enlargement of the tail of the epididymis are characteristics 
of the chronic phase of disease in males. The macroscopic 
appearance of the testes is usually normal, but granulomas 
and calcifi cation may be apparent on the cut surface. The 
affected epididymis appears fi rm, showing a white cut 
surface as a consequence of connective tissue proliferation. 
One or more abscesses fi lled with creamy or caseous 
substances may be observed in the thick connective tissue. 
Vesicular glands can show enlargement and altered cut 
surfaces with dilated ducts, either empty or fi lled with fl uid. 
Abscesses or other purulent lesions can also be found in 
non-reproductive organs, particularly the lymph nodes, 
spleen, liver, kidneys, joint capsules, tendon sheaths, bones, 
mammary gland, urinary bladder and, occasionally, the 
33 Rev. sci. tech. Off. int. Epiz., 32 (1)
brain. Nodular splenitis, arthritis, bursitis and osteomyelitis 
of the vertebral bodies have been reported in some species. 
Swollen joints and tendon sheaths, accompanied by 
lameness and lack of coordination, can occur. Less common 
signs include posterior paralysis, spondylitis and abscess 
formation in various organs (100). 
In fetuses infected with Brucella spp., a series of pathological 
changes occur, including pneumonia and sero-haemorrhagic 
lesions in body cavities and muscles. Other lesions, such as 
abnormal abomasal content, fi brinous pleuritis, vasculitis 
and meningitis, occur less frequently. Fetal bacteraemia 
occurs after replication of Brucella spp. in trophoblasts. 
Fetal viscera and placental cotyledons subsequently become 
heavily infected with Brucella spp. Histological lesions 
observed in aborted fetuses are not specifi c enough to be 
able to identify Brucella as the cause of abortion. In chronic 
cases, uni- and bilateral hygromas, mainly localised at the 
carpal joint, can be observed in a signifi cant proportion of 
infected animals (100).
Diagnosis
Brucellosis signs are non-pathognomonic in livestock or 
wildlife, and defi nitive diagnosis depends on laboratory 
testing. Laboratory diagnosis includes indirect tests that can 
be applied to milk or blood, as well as direct tests (classical 
bacteriology and direct polymerase chain reaction or PCR-
based methods). The choice of a particular testing strategy 
depends on the prevailing epidemiological situation of 
brucellosis in susceptible animals (livestock and wildlife) 
within a country or region. Isolation of Brucella spp. (or 
specifi c DNA detection by PCR) allows certainty of diagnosis. 
Biotyping provides important epidemiological information 
which allows tracing back to the source of infection 
in countries in which several biotypes are circulating. 
However, when one particular biovar is overwhelmingly 
the most frequently isolated strain in a country or region, 
classical typing techniques are of no help. In this context, 
new fi ngerprinting methods, such as Multiple Locus 
Variable [number of tandem repeat] Analysis (MLVA) and 
Multi Locus Sequence Analysis (MLSA), are gaining wider 
acceptance and are being routinely used for typing and 
fi ngerprinting of isolates for epidemiological purposes (54).
Direct diagnosis
Several techniques are available to identify Brucella spp. The 
staining of smears from pathological material is still often 
used, and can provide valuable information from abortive 
material (3). Bacterial isolation is nevertheless always 
preferable and often required for genotyping strains. New 
PCR techniques allowing the identifi cation and typing of 
Brucella have been developed and are being implemented 
in specialised diagnostic laboratories (11, 54, 55), but the 
performance of these molecular methods for direct diagnosis 
of brucellosis from fi eld samples still needs to be improved.
Staining
Brucella is a coccobacillus, measuring 0.6 µm to 1.5 µm long 
and 0.5 µm to 0.7 µm wide. Morphologically, Brucella is 
generally present as individual bacteria, but can occasionally 
be observed in clumps of two or more. Brucella is a Gram-
negative bacterium that can resist weak acidic treatment 
and therefore appears red after Stamp staining. However, 
this staining is not specifi c enough and other pathogens, 
such as Chlamydophila abortus (formerly Chlamydia psittaci) 
and Coxiella burnetii, also stain in the same way and have a 
similar morphology (3).
Culture
The isolation of Brucella from a given animal is the only 
diagnosis of certainty. The choice of samples depends 
on the observed clinical signs. In the case of clinical 
brucellosis, adequate samples include: vaginal secretions, 
colostrum, milk, aborted fetuses (stomach, spleen and 
lung), fetal membranes, sperm and fl uid collected from 
arthritis or hygroma. Post mortem, the preferred tissues 
are the genital organs, the spleen and the following 
lymph nodes: oropharyngeal, iliac, scapular, crural and 
supramammary/testicular lymph nodes. Bacteriological 
diagnosis of brucellosis is performed by culturing these 
animal samples (once properly homogenised) directly 
on both Farrell’s (FM) and modifi ed Thayer-Martin’s 
(mTM) culture media. However, despite inhibiting most 
contaminating microorganisms, the FM also inhibits the 
growth of some Brucella strains. However, the mTM is 
adequate for all Brucella species but only partially inhibitory 
for contaminants. A new selective medium (CITA) is more 
sensitive than both mTM and FM for isolating all Brucella 
species from fi eld samples (19). The simultaneous use 
of both FM and CITA media improves the diagnostic 
performance of the culture. Visible colonies may appear 
after three to four days, but cultures can only be considered 
negative after seven days of incubation. The presumptive 
identifi cation of Brucella spp. is conducted by analysis of 
colonial morphology, Gram staining, and the catalase, 
oxidase and urease tests (3).
Biotyping
Defi nitive identifi cation and biotyping of Brucella colonies 
are performed by using various classical microbiological 
tests. The most important are: the dependence on serum 
and CO2 for growth, the production of H2S, growth in 
the presence of some dyes, agglutination with specifi c 
antisera and lysis by specifi c phages (3). To conduct these 
tests profi ciently, submitting the isolated strains to an 
internationally recognised laboratory for defi nitive typing 
is recommended.
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Molecular identifi cation and typing methods
Molecular identifi cation
Several PCR-based methods have been developed. The 
best are based on the detection of specifi c sequences of 
Brucella spp., such as the 16S-23S genes, the IS711 insertion 
sequence (which has, so far, only been detected in Brucella 
spp.) or the bcsp31 gene encoding for a 31 kilodalton (kDa) 
protein (6, 70). These techniques have been used on human 
samples but have become more widely applied in veterinary 
medicine. However, their relatively low sensitivity, high 
cost and the lack of standardisation have limited their 
application to specifi c problems, such as wildlife studies. It 
is diffi cult to provide sensitivity and specifi city estimates for 
these techniques because the test protocols described in the 
published literature differ greatly. As a general rule, these 
techniques show a signifi cantly lower diagnostic sensitivity 
than culture but, depending on the samples and animal 
species considered, their specifi city is close to 100% (10).
Molecular typing
The AMOS PCR has been used to type Brucella spp. (12). 
(AMOS is an acronym for the Brucella species: B. abortus, 
melitensis, ovis and suis.) This test allows discrimination 
among Brucella species and between vaccine and wild-
type strains but does not allow differentiation between 
the biovars of a given Brucella species. However, not all 
the biovars of B. abortus (biovars 3, 5, 6, 7, 9) and B. suis 
(biovars 2, 3, 4, 5), some of which are epidemiologically 
important in Europe, can be identifi ed in this assay. A newly 
developed multiplex PCR assay (named Bruce-ladder) can, 
for the fi rst time, identify and differentiate between all the 
Brucella species and the vaccine strains in the same test (55).
New techniques appear promising, such as single nucleotide 
polymorphism signatures (SNPs), aimed at detecting DNA 
sequence variations that occur when a single nucleotide in 
the genome differs between members of a species; MLSA, 
aimed at directly measuring the DNA sequence variations 
in a set of housekeeping genes and characterising strains by 
their unique allelic profi les; and MLVA, which analyses the 
variability of loci presenting repeated sequences (54, 96). 
Indirect diagnostic tests
A number of serological studies have been performed on 
brucellosis in wildlife, as well as in zoo collections, with 
the goal of assessing the prevalence of Brucella spp. within 
different wild species. Brucellosis serology in wildlife is 
usually performed using the same antigens as in domestic 
ruminants because the Brucella immunodominant antigens 
are associated with the surface ‘smooth’ lipopolysaccharide 
(sLPS), which is shared by all the naturally occurring biovars 
of B. abortus, B. melitensis, B. suis, B. neotomae, B. microti, 
B. ceti, B. pinnipedialis and B. inopinata. It is important to 
note that the remaining species of the genus (B. ovis and 
B. canis) present on their surface a ‘rough’ LPS, which is 
antigenically different from the sLPS. This means that 
infections by these two rough Brucella species cannot be 
detected by the classical serological tests used for detecting 
antibodies against sLPS. Tests detecting rough LPS Brucella 
infections will not be discussed further because of their 
limited importance in wildlife.
It should be emphasised that it is impossible to determine 
which species of Brucella has induced antibodies against 
sLPS in the host and thus the gold standard in brucellosis 
diagnosis is the isolation of the bacteria. A sound testing 
strategy is fi rst to estimate the apparent prevalence of 
brucellosis in wildlife by serology, and then attempt to 
isolate the bacteria from a selected subset of samples.
Wildlife brucellosis ecology can be divided into infection 
rate, attack rate (progress to become clinical) and mortality/
morbidity rate (chronic carrier state) (25). With the shift 
to the detection of a pre- or subclinical disease (as in the 
context of brucellosis control and eradication programmes 
in livestock) and the identifi cation of brucellosis in wildlife 
populations, the ecology of wildlife brucellosis has become 
more and more important when analysing serological results, 
and the emphasis should be put on the predictive value of 
test results, i.e. the clinical, ecological and epidemiological 
usefulness of the results (52).
Most serological brucellosis tests used in wildlife brucellosis 
studies have been directly transposed, without any previous 
validation, from their use in domestic livestock populations 
(in which, quite often, unfortunately, these tests have not 
been validated either). Moreover, some of these assays rely on 
species-specifi c reagents that are not commercially available.
To determine the apparent prevalence of brucellosis in 
wildlife, simple classical tests, such as the Rose Bengal 
test, may be recommended. However, this classical test 
requires high-quality serum and, unfortunately, gathering 
high-quality serum samples from wildlife is frequently 
impossible. Therefore, recent brucellosis studies in wildlife 
have been based on enzyme-linked immunosorbent assays 
(ELISAs) (99) and fl uorescence polarization assays (34). The 
degree of haemolysis and the ‘quality’ of serum samples do 
not signifi cantly affect the diagnostic performance of these 
tests. The lack of availability of polyclonal or monoclonal 
antibodies that detect immunoglobulins in different wildlife 
species can be overcome in indirect ELISA, by using either 
Protein A or Protein G as conjugates (46, 61, 64).
Bacteria such as Yersinia enterocolitica O:9 induce serological 
cross-reactions in the brucellosis serological tests that are 
almost indistinguishable from true brucellosis serological 
reactions (39, 62, 82, 95). Other cross-reactive bacteria exist 
in wildlife, for example, Francisella tularensis, an important 
pathogen in hares (50). Thus, false-positive serological 
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reactions should always be taken into account for a sound 
interpretation of serological results in the absence of 
bacterial isolation. The parallel use of sLPS-based tests and 
tests detecting specifi c antibodies directed against Brucella 
cytoplasmic proteins, as documented in moose (21) and elk 
(53), could be of some help to differentiate cross-reactions 
from antibody responses due to true Brucella spp. infection.
Another approach could be based on assessing cell-
mediated immunity, through in vivo (skin) tests or in vitro 
tests (proliferation assays or cytokine detection assays) 
against specifi c Brucella cytoplasmic proteins. Some of 
these approaches have been applied in domestic animals, 
particularly cattle (76, 82), and their effi cacy could be 
estimated in wildlife. It is also important to acknowledge 
that, although brucellosis tests are usually adequate to 
detect an infected group of animals, they can have important 
limitations in detecting infected individuals.
Management and control
In Europe, wildlife brucellosis does not receive the attention 
it is currently receiving in the USA, where there is a wildlife 
reservoir of B. abortus in bison and elk in the GYA. 
Notwithstanding the fact that the use of vaccine in 
wildlife should always be carefully considered, there is no 
brucellosis vaccine currently available that gives satisfactory 
results in terms of safety and effi cacy in wildlife (17). 
However, in bison, calfhood RB51 vaccination conferred 
some reduced protection, as compared to the protection 
conferred in cattle (67). Vaccination is unlikely to eradicate 
B. abortus from Yellowstone bison, but could be an effective 
tool for reducing the level of infection (92). Therefore, a 
combination of novel brucellosis management strategies 
and public education to balance conservation, economic 
and public health issues will be required (75). However, 
the isolation of the S19 cattle vaccine from feral pigs (90) 
highlights the fact that, before any prospective use of a 
brucellosis vaccine in wildlife, the release of such a vaccine 
must be fully investigated, particularly in non-target species 
(17). Although some tools are currently available for use in 
the wildlife reservoirs, the development of new vaccines, 
diagnostics and management procedures will most likely be 
needed to gain effective control of brucellosis (66). 
Nowadays, the control of brucellosis in wildlife should be 
based almost exclusively on good management practices, 
and it is thus vital to assess them. As dramatically shown in 
the GYA, elk (considered to be dead-end hosts when ranging 
freely) are becoming maintenance hosts for B. abortus 
when winter feeding is practised (93). As a general rule, 
management practices enhancing the wildlife/livestock 
interface should not be implemented.
In Europe, brucellosis in terrestrial wildlife is nowadays 
mostly restricted to B. suis biovar 2 infections in wild boar 
and hares. Given the ecology and geographical distribution 
of wild boar in Europe, B. suis biovar 2 infection in wild boar 
is of major concern for outdoor pigs in the EU. Moreover, 
B. suis biovar 2 can also spill over into cattle, as recently 
reported in Belgium (98).
The importance of B. microti, for which soil may be the 
reservoir, still needs to be assessed and its pathogenicity 
for wild rodent species and foxes remains to be properly 
determined.
Zoonotic concern
Brucellosis is an ancient disease with a low fatality rate (less 
than 2% of untreated cases). Yet human brucellosis remains 
the most common zoonotic disease worldwide, with 
more than 500,000 new cases every year. It is associated 
with substantial residual disability and is an important 
cause of travel-associated morbidity (72). However, direct 
transmission of Brucella spp. from wildlife to humans seems 
to be restricted to the butchering of meat and the dressing 
of carcasses, for feral pig meat (20, 84) and African buffalo 
bushmeat (2). In the Arctic, there is a close tie between native 
communities and animals, especially reindeer/caribou, both 
for nutrition and as an important part of the communities’ 
culture. In this respect, the consumption of raw bone 
marrow and internal organs from freshly killed caribou is 
an important risk factor for B. suis biovar 4 infection. In 
contrast to B. suis biovars 1, 3 and 4, B. suis biovar 2 has 
rarely been isolated from humans, and its zoonotic role is 
questioned (42).
Signifi cance and implications 
for livestock and wildlife health
In 1991, Professor Paul Nicoletti, from the College of 
Veterinary Medicine at the University of Florida, said, 
during an interview: ‘I encourage my veterinary students 
to pick a “survivor”, a disease that will provide a lifetime of 
challenging and rewarding work. Brucellosis is notorious for 
being a survivor.’ From the fi rst description of B. melitensis 
as an agent of Malta fever by David Bruce in 1887 to the 
discovery of a new worldwide ecological niche of Brucella 
spp. in marine mammals, brucellosis has always been of 
concern (42).
In Europe, given the progress of national bovine brucellosis 
eradication programmes, it is unlikely that B. abortus will 
establish itself in free-ranging wild ungulates. The same can 
probably be said for B. melitensis, although foci of infection 
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in small ruminants remain important in some Southern 
European states and in the Balkans. In the future, probably 
only anecdotic spillover from small ruminants to wild 
ungulates will be reported in the EU.
Although brucellosis has been eradicated from the 
domestic pig population in Europe for decades, B. suis biovar 
2 infection in wild boar (which is a sustainable infection 
in almost all European wild boar populations) is of major 
concern for pigs reared outdoors, should brucellosis control 
programmes in domestic pigs be implemented in the EU 
Member States. 
With particular reference to wildlife brucellosis, it is 
amazing to see that the epidemiology and ecology of the 
infection are still so poorly understood. For decades, 
scientists speculated on whether brucellosis induced 
abortion in bison (71). Little is known about the pathology 
and biological signifi cance of B. suis biovar 2 in wild boar 
(44). The geographical distribution of brucellosis in the 
European brown hare is not known but data suggest that 
its prevalence is less important than it is in wild boar, and 
that foci of infections show a patchy pattern, most probably 
due to the ecology of hares (49). Nevertheless, translocation 
of infected hares, in the absence of brucellosis regulations, 
may contribute to the disease’s dissemination in Europe. 
At present, there are many taxonomical issues related 
to Brucella isolates which may lead to the description 
of new species and/or biovars in the near future (96). 
Lastly, the recent discovery of Brucella-like organisms 
from non-human primates (85) and African bullfrogs 
(Pyxicephalus edulis) originating from Tanzania (22) poses 
new challenges for our understanding of the genus Brucella 
and brucellosis at the wildlife/livestock/human interface.
 Brucellose dans la faune sauvage terrestre
J. Godfroid, B. Garin-Bastuji, C. Saegerman & J.M. Blasco
Résumé
Le lien épidémiologique entre brucellose dans la faune sauvage et brucellose des 
animaux domestiques et de l’homme est largement établi. Lors d’études sur la 
brucellose dans la faune sauvage, trois questions doivent être posées : (i) s’agit-il 
d’une infection résiduelle trouvant son origine chez les animaux domestiques ou 
bien s’agit-il d’une infection durable dans une ou plusieurs espèces sauvages ? 
(ii) la brucellose dans la faune sauvage constitue-t-elle un réservoir pour 
les animaux domestiques ? (iii) y a-t-il un risque zoonotique ? Nonobstant leur 
préférence d’hôtes, Brucella abortus et B. suis ont été isolées de nombreuses 
espèces sauvages, alors que B. melitensis est plus rarement rapportée dans la 
faune sauvage. La pathogénicité de Brucella spp. chez les animaux sauvages 
n’est pas bien connue. La prévalence de la brucellose chez certaines espèces 
sauvages est très faible et partant, le comportement individuel des animaux 
sauvages ainsi que les interactions entre faune sauvage et animaux domestiques 
sont les facteurs de risque les plus importants pour la transmission de l’agent 
pathogène. Les signes cliniques de la maladie n’étant pas pathognomoniques, le 
diagnostic défi nitif se fonde sur des tests de laboratoire incluant des tests indirects 
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Brucelosis en la fauna silvestre terrestre
J. Godfroid, B. Garin-Bastuji, C. Saegerman & J.M. Blasco
Resumen
La existencia de relaciones epidemiológicas entre las enfermedades de 
los animales domésticos y las que afectan a las especies silvestres es un 
hecho bien establecido. En el caso concreto de la brucelosis, tres cuestiones 
importantes son objeto de debate: (i) ¿la presencia de brucelosis en los animales 
silvestres se produce como consecuencia de la transmisión desde el reservorio 
doméstico, o bien existen reservorios silvestres en los que la enfermedad se 
mantiene de manera sostenida? (ii) ¿la fauna silvestre representa realmente un 
reservorio de Brucella para el ganado doméstico? y (iii) ¿la eventual presencia 
de brucelosis en la fauna silvestre representa un riesgo para la salud humana? 
Pese a poseer distintos hospedadores preferentes, tanto B. abortus como 
B. suis se han aislado en varias especies animales silvestres, lo que resulta 
mucho menos frecuente con B. melitensis. La patogénesis de Brucella spp. en 
las especies silvestres no se ha defi nido todavía con sufi ciente precisión y su 
prevalencia es generalmente baja o muy baja, por lo que el comportamiento 
individual y las interacciones entre fauna silvestre y ganado doméstico son los 
factores de mayor relevancia epidemiológica en la potencial transmisión de la 
enfermedad. Puesto que los signos clínicos de la infección no son patognomónicos, 
su diagnóstico defi nitivo dependerá del resultado de las pruebas laboratoriales 
directas o indirectas. Puesto que las pruebas indirectas, basadas normalmente 
en el diagnóstico serológico en muestras de sangre o leche, no pueden 
identifi car la especie de Brucella involucrada, es preciso recurrir, siempre que 
sea posible, al diagnóstico bacteriológico utilizando técnicas clásicas o aquellas 
basadas en la biología molecular (reacción en cadena de la polimerasa o PCR). 
Sin embargo, las pruebas serológicas no son capaces de determinar contra qué 
effectués sur le sang ou le lait ainsi que des tests directs (bactériologie classique 
ou des méthodes basées sur la réaction de polymérisation en chaîne [PCR]). 
Cependant, la sérologie ne permet pas de déterminer quelle espèce de Brucella 
a induit la présence d’anticorps chez l’hôte. Seul l’isolement de Brucella spp. (ou 
la détection d’une séquence d’ADN spécifi que par PCR) permet un diagnostic 
défi nitif en utilisant des techniques classiques et moléculaires d’identifi cation 
et de typage des souches. Il n’y a, actuellement, aucun vaccin anti-brucellique 
montrant un degré satisfaisant d’innocuité et d’effi cacité pour la faune sauvage. 
C’est pourquoi le contrôle de la brucellose dans la faune sauvage doit reposer 
sur des techniques de gestion adaptées. À l’heure actuelle, la transmission de 
Brucella spp. de la faune sauvage à l’homme semble liée à la préparation et à la 
consommation de carcasses de sangliers ou de porcs sauvages infectés dans 
le monde développé et de viande de brousse (buffl e africain) dans les pays en 
développement. Dans l’Arctique, la consommation traditionnelle de moelle 
osseuse et d’organes internes crus de caribous ou de rennes fraîchement abattus 
constitue un facteur de risque important.
Mots-clés
Bactériologie – Brucella spp. – Brucellose – Épidémiologie – Faune sauvage – Interface 
animaux sauvages/animaux domestiques – Sérologie.
38  Rev. sci. tech. Off. int. Epiz., 32 (1)
especie de Brucella están dirigidos los anticuerpos detectados en el hospedador. 
Solo el aislamiento de la bacteria (o la detección de su ADN específi co por 
PCR) constituye un diagnóstico defi nitivo, recurriendo a técnicas clásicas o 
moleculares  para identifi car y caracterizar las cepas específi cas.
Puesto que ninguna de las vacunas existentes para el ganado doméstico ha 
demostrado ser efi caz para prevenir la brucelosis en los animales silvestres, 
el control de la enfermedad en estas especies debe basarse en adecuadas 
prácticas de manejo, evitando en la medida de lo posible la interacción entre 
las especies domésticas y las silvestres. La transmisión de la enfermedad a la 
especie humana desde los animales silvestres es un evento raro, y que queda 
restringido normalmente al procesado y consumo de órganos de cerdo o jabalí 
infectados en el mundo desarrollado, o de órganos y leche del búfalo africano en 
los países en desarrollo. Por otra parte, el consumo tradicional de médula ósea u 
órganos internos crudos de reno y caribú puede representar un riesgo potencial 
de transmisión al hombre en el Ártico.
Palabras clave
Bacteriología – Brucella spp. – Brucelosis – Epidemiología – Fauna silvestre – Interfaz 
ganado doméstico/animales silvestres – Serología.
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